These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 25071336)

  • 21. Biliary atresia and other cholestatic childhood diseases: Advances and future challenges.
    Verkade HJ; Bezerra JA; Davenport M; Schreiber RA; Mieli-Vergani G; Hulscher JB; Sokol RJ; Kelly DA; Ure B; Whitington PF; Samyn M; Petersen C
    J Hepatol; 2016 Sep; 65(3):631-42. PubMed ID: 27164551
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical problems with developmental anomalies of the biliary tract.
    Suchy FJ
    Semin Gastrointest Dis; 2003 Oct; 14(4):156-64. PubMed ID: 14719766
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Anatomic anomalies in neonatal cholestatic jaundice].
    Houwen RH; Bax NM
    Tijdschr Kindergeneeskd; 1993 Aug; 61(4):151-7. PubMed ID: 8122227
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MDR3 (ABCB4) defects: a paradigm for the genetics of adult cholestatic syndromes.
    Trauner M; Fickert P; Wagner M
    Semin Liver Dis; 2007 Feb; 27(1):77-98. PubMed ID: 17295178
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Potential of ileal bile acid transporter inhibition as a therapeutic target in Alagille syndrome and progressive familial intrahepatic cholestasis.
    Kamath BM; Stein P; Houwen RHJ; Verkade HJ
    Liver Int; 2020 Aug; 40(8):1812-1822. PubMed ID: 32492754
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pediatric Cholestatic Diseases: Common and Unique Pathogenic Mechanisms.
    Sutton H; Karpen SJ; Kamath BM
    Annu Rev Pathol; 2024 Jan; 19():319-344. PubMed ID: 38265882
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical and pathological characteristics of Alagille syndrome in Chinese children.
    Wang JS; Wang XH; Zhu QR; Wang ZL; Hu XQ; Zheng S
    World J Pediatr; 2008 Nov; 4(4):283-8. PubMed ID: 19104892
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of Cholestasis in Infants and Young Children.
    Heinz N; Vittorio J
    Curr Gastroenterol Rep; 2023 Nov; 25(11):344-354. PubMed ID: 37651067
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rodent models of cholestatic liver disease: A practical guide for translational research.
    Gijbels E; Pieters A; De Muynck K; Vinken M; Devisscher L
    Liver Int; 2021 Apr; 41(4):656-682. PubMed ID: 33486884
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Surgical outcomes in Alagille syndrome and PFIC: A single institution's 20-year experience.
    Flores CD; Yu YR; Miloh TA; Goss J; Brandt ML
    J Pediatr Surg; 2018 May; 53(5):976-979. PubMed ID: 29729773
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnostic and therapeutic approach to cholestatic liver disease.
    Pérez Fernández T; López Serrano P; Tomás E; Gutiérrez ML; Lledó JL; Cacho G; Santander C; Fernández Rodríguez CM
    Rev Esp Enferm Dig; 2004 Jan; 96(1):60-73. PubMed ID: 14971998
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endoscopic approach to the patient with congenital anomalies of the biliary tract.
    Liu QY; Nguyen V
    Gastrointest Endosc Clin N Am; 2013 Apr; 23(2):505-18. PubMed ID: 23540973
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Medical management of chronic cholestatic liver diseases.
    Gossard AA; Lindor KD
    Can J Gastroenterol; 2000 Nov; 14 Suppl D():93D-98D. PubMed ID: 11110620
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cholestasis and cholestatic syndromes.
    O'Leary JG; Pratt DS
    Curr Opin Gastroenterol; 2007 May; 23(3):232-6. PubMed ID: 17414837
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biliary atresia is associated with CD4+ Th1 cell-mediated portal tract inflammation.
    Mack CL; Tucker RM; Sokol RJ; Karrer FM; Kotzin BL; Whitington PF; Miller SD
    Pediatr Res; 2004 Jul; 56(1):79-87. PubMed ID: 15128911
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnostic utility of hepatobiliary scintigraphy with 99mTc-DISIDA in neonatal cholestasis.
    Spivak W; Sarkar S; Winter D; Glassman M; Donlon E; Tucker KJ
    J Pediatr; 1987 Jun; 110(6):855-61. PubMed ID: 3585600
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatobiliary complications of oral contraceptives.
    Lindberg MC
    J Gen Intern Med; 1992; 7(2):199-209. PubMed ID: 1336797
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of drug transporter pharmacogenetics on cholestasis.
    Dietrich CG; Geier A
    Expert Opin Drug Metab Toxicol; 2014 Nov; 10(11):1533-51. PubMed ID: 25260651
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of the Patient- and Observer-Reported PRUCISION Instruments to Assess Pruritus and Sleep Disturbance in Pediatric Patients with Cholestatic Liver Diseases.
    Gwaltney C; Bean S; Venerus M; Karlsson L; Warholic N; Kjems L; Horn P
    Adv Ther; 2022 Nov; 39(11):5126-5143. PubMed ID: 36066744
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ABCB4 mutations in adult patients with cholestatic liver disease: impact and phenotypic expression.
    Degiorgio D; Crosignani A; Colombo C; Bordo D; Zuin M; Vassallo E; Syrén ML; Coviello DA; Battezzati PM
    J Gastroenterol; 2016 Mar; 51(3):271-80. PubMed ID: 26324191
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.